Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Enprostil, (1alpha(r*),2beta(1e,3r*),3alpha)-(+-)-isomer
2. Enprostil, (1alpha(r*),2beta(1e,3s*),3alpha)-(+-)-isomer
3. Enprostil, (1alpha,2alpha(1e,3s*),3beta)-(+-)-isomer
4. Enprostil, (1alpha,2beta(1e,3r*),3alpha)-(+-)-isomer
5. Enprostil, (1r-(1(r*),2beta(1e,3r*),3alpha))-isomer
6. Enprostil, (1r-(1alpha(s*),2beta(1e,3r*),3alpha))-isomer
7. Enprostil, (1r-(1alpha,2beta(1e,3r*),3alpha))-isomer
8. Enprostil, (1s-(1alpha(r*),2beta(1e,3r*),3alpha))-isomer
9. Enprostil, (1s-(1alpha(s*),2beta(1e,3r*),3alpha))-isomer
10. Gardrin
11. Rs 84135
12. Rs-84135
13. Rs84135
1. 73121-56-9
2. Camleed
3. Gardrin
4. Rs-84135
5. Rs 84135-004
6. Gardrine
7. Syngard
8. Enprostil (jan/usan/inn)
9. Camleed (tn)
10. Rs-86505-007
11. Schembl186877
12. Gtpl1918
13. Chembl2104194
14. Dtxsid401021647
15. Ex-a6212
16. Zinc3812898
17. Akos016014109
18. D01891
19. Methyl 7-[(1r,2r,3r)-3-hydroxy-2-[(e,3r)-3-hydroxy-4-(phenoxy)but-1-enyl]-5-oxocyclopentyl]hepta-4,5-dienoate
| Molecular Weight | 400.5 g/mol |
|---|---|
| Molecular Formula | C23H28O6 |
| XLogP3 | 1.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 11 |
| Exact Mass | 400.18858861 g/mol |
| Monoisotopic Mass | 400.18858861 g/mol |
| Topological Polar Surface Area | 93.1 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 613 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
A - Alimentary tract and metabolism
A02 - Drugs for acid related disorders
A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
A02BB - Prostaglandins
A02BB02 - Enprostil
ABOUT THIS PAGE
A Enprostil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Enprostil, including repackagers and relabelers. The FDA regulates Enprostil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Enprostil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Enprostil supplier is an individual or a company that provides Enprostil active pharmaceutical ingredient (API) or Enprostil finished formulations upon request. The Enprostil suppliers may include Enprostil API manufacturers, exporters, distributors and traders.
click here to find a list of Enprostil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Enprostil DMF (Drug Master File) is a document detailing the whole manufacturing process of Enprostil active pharmaceutical ingredient (API) in detail. Different forms of Enprostil DMFs exist exist since differing nations have different regulations, such as Enprostil USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Enprostil DMF submitted to regulatory agencies in the US is known as a USDMF. Enprostil USDMF includes data on Enprostil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Enprostil USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Enprostil suppliers with USDMF on PharmaCompass.
Enprostil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Enprostil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Enprostil GMP manufacturer or Enprostil GMP API supplier for your needs.
A Enprostil CoA (Certificate of Analysis) is a formal document that attests to Enprostil's compliance with Enprostil specifications and serves as a tool for batch-level quality control.
Enprostil CoA mostly includes findings from lab analyses of a specific batch. For each Enprostil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Enprostil may be tested according to a variety of international standards, such as European Pharmacopoeia (Enprostil EP), Enprostil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Enprostil USP).
LOOKING FOR A SUPPLIER?
